<DOC>
	<DOC>NCT01674894</DOC>
	<brief_summary>This post-marketing, single-center prospective study will be conducted in an open-label, non-interventional setting, for women seeking fertility treatment and will describe cleavage dynamics in relation to the age of the oocyte and gonadotrophin treatment.</brief_summary>
	<brief_title>Study of the Cleavage of the Egg in Relation to the Stimulation Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Infertility, Female</mesh_term>
	<criteria>1. IVF/ICSI treatment 2. Regular cycles of 2535 days 3. Follicle stimulation with Bravelle and/or Menopur 4. Women aged 3835 years 5. Long agonist or short antagonist treatment 6. Willing and able to understand a Danish, English or German patient information form 7. Willing and able to provide written Informed Consent 1. BMI more than 35 2. Presence of hydrosalpinx on ultrasound 3. FSH more than 13 or antral follicle count (AFC) less than 4 at fertility investigation 4. Known allergic reactions to the planned medications 5. Use of testicular sperm</criteria>
	<gender>Female</gender>
	<minimum_age>38 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>